Exclusive

Publication

Byline

Taiwan's PharmaEssentia invests $46 M to build manufacturing plant in Puerto Rico

Singapore, Feb. 16 -- PharmaEssentia Corporation, a global biopharmaceutical company headquartered in Taiwan with deep expertise in the development of novel biologics for hematology and oncology, and ... Read More


WHO prequalifies Biological E's oral polio vaccine

Singapore, Feb. 16 -- The World Health Organization (WHO) hasprequalified an additional novel oral polio vaccine type 2 (nOPV2), further strengthening the global supply of a vaccine at the heart of ef... Read More